Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab

Brueggemann, C.; Kirchberger, M. C.; Goldinger, S. M.; Weide, B.; Konrad, A.; Erdmann, M.; Schadendorf, D.; Croner, R. S.; Krahenbuhl, L.; Kaehler, K. C.; Hafner, C.; Leisgang, W.; Kiesewetter, F.; Dummer, R.; Schuler, G.; Stuerzl, M.; Heinzerling, L.

dc.contributor.author	Weide, Benjamin Matthias
dc.date.accessioned	2019-04-30T14:01:53Z
dc.date.available	2019-04-30T14:01:53Z
dc.date.issued	2017
dc.identifier.issn	1432-1335
dc.identifier.uri	http://hdl.handle.net/10900/88321
dc.language.iso	en	de_DE
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00432-017-2450-2	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Predictive value of PD-L1 based on mRNA level in the treatment of stage IV melanoma with ipilimumab	de_DE
dc.type	Article	de_DE
utue.quellen.id	20190131163842_01051
utue.publikation.seiten	1977-1984	de_DE
utue.personen.roh	Brueggemann, C.
utue.personen.roh	Kirchberger, M. C.
utue.personen.roh	Goldinger, S. M.
utue.personen.roh	Weide, B.
utue.personen.roh	Konrad, A.
utue.personen.roh	Erdmann, M.
utue.personen.roh	Schadendorf, D.
utue.personen.roh	Croner, R. S.
utue.personen.roh	Krahenbuhl, L.
utue.personen.roh	Kaehler, K. C.
utue.personen.roh	Hafner, C.
utue.personen.roh	Leisgang, W.
utue.personen.roh	Kiesewetter, F.
utue.personen.roh	Dummer, R.
utue.personen.roh	Schuler, G.
utue.personen.roh	Stuerzl, M.
utue.personen.roh	Heinzerling, L.
dcterms.isPartOf.ZSTitelID	Journal of Cancer Research and Clinical Oncology	de_DE
dcterms.isPartOf.ZS-Issue	10	de_DE
dcterms.isPartOf.ZS-Volume	143	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE